Ophthalmology Service, Hospital Cruz Roja, Madrid, Spain.
Ophthalmology. 2011 Feb;118(2):265-71. doi: 10.1016/j.ophtha.2010.06.035. Epub 2010 Sep 29.
To evaluate ocular surface histopathologic changes and ocular sequelae in the follow-up of patients with toxic epidermal necrolysis (TEN).
Prospective, consecutive, comparative, interventional case series.
Eleven patients (22 eyes) with TEN that developed after drug treatment and 33 normal subjects as the control group.
Toxic epidermal necrolysis diagnosis was based on data obtained from medical records. Only patients with ocular involvement in the acute stage were included. Patients and controls underwent a complete ophthalmic assessment, including tear film evaluation and corneal and conjunctival impression cytology. These were performed at the beginning of the study (∼1 month after TEN) and 6 and 12 months later. Tear film production and stability were evaluated by break-up time, Schirmer's test with anesthesia, rose bengal, and fluorescein staining pattern. Conjunctival retraction was determined by studying the vanishing point in eye abduction of the lacunar folds.
Break-up time, Schirmer's test, fluorescein and rose bengal stain, corneal and conjunctival epithelial squamous metaplasia, conjunctival retraction, and ocular sequelae.
Mild or moderate ocular involvement was present in 73% of patients in the acute stage. Ocular involvement was not related to TEN severity, area of skin involvement, or drug etiology. One-year follow-up, ocular manifestations, slit-lamp findings, and epithelial cell squamous metaplasia were related to ocular involvement severity in the acute phase. We found pathologic conjunctival retraction in 86.4% of patients. Decreased levels of break-up time and Schirmer's test were found in patients with TEN. Conjunctival cytology showed a marked decrease in goblet cell density. No patients died, and there were no recurrences of TEN during the study.
Ocular involvement in the acute stage was not related to TEN severity or etiology. Ocular sequelae were related to ocular involvement severity in the acute phase. Early ophthalmic assessment and frequent follow-up are helpful because ocular involvement represents the first long-term complication in patients with TEN. Impression cytology and measurement of conjunctival retraction can be useful tools in the assessment of dynamic ocular changes in patients with TEN.
评估中毒性表皮坏死松解症(TEN)患者的眼部表面组织病理学变化和眼部后遗症。
前瞻性、连续、对比、干预性病例系列研究。
11 名(22 只眼)因药物治疗而患有 TEN 的患者和 33 名正常受试者作为对照组。
TEN 的诊断基于病历中获得的数据。仅纳入急性期有眼部受累的患者。患者和对照组均接受全面的眼科评估,包括泪膜评估以及角膜和结膜印片细胞学检查。这些检查在研究开始时(TEN 后约 1 个月)以及 6 个月和 12 个月后进行。通过泪膜破裂时间、麻醉性 Schirmer 试验、玫瑰红染色和荧光素染色模式评估泪膜产生和稳定性。通过研究 lacunar 褶皱眼外展时的消失点来确定结膜退缩。
泪膜破裂时间、Schirmer 试验、荧光素和玫瑰红染色、角膜和结膜上皮鳞状化生、结膜退缩和眼部后遗症。
急性期 73%的患者有轻度或中度眼部受累。眼部受累与 TEN 的严重程度、皮肤受累面积或药物病因无关。1 年随访时,眼部表现、裂隙灯检查结果和上皮细胞鳞状化生与急性期的眼部受累严重程度有关。我们发现 86.4%的患者存在病理性结膜退缩。TEN 患者的泪膜破裂时间和 Schirmer 试验值降低。结膜细胞学显示杯状细胞密度明显降低。研究期间无患者死亡,也无 TEN 复发。
急性期的眼部受累与 TEN 的严重程度或病因无关。眼部后遗症与急性期的眼部受累严重程度有关。早期眼科评估和频繁随访很有帮助,因为眼部受累是 TEN 患者的第一个长期并发症。结膜印片细胞学和结膜退缩测量可作为评估 TEN 患者动态眼部变化的有用工具。